Todd Thomson

Insider Reports History

Entity
Individual
Location
11730 Hull Street Road, Midlothian, VA
Signature
/s/ Todd Thomson
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Todd Thomson:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Chardan NexTech Acquisition 2 Corp. Director Common Stock, par value $0.0001 22K $94.2K $4.28 Aug 10, 2021 Direct
ACTUATE THERAPEUTICS, INC. Director, 16.4% Owner Common Stock 1.18M Aug 14, 2024 By KVP II, L.P.
ACTUATE THERAPEUTICS, INC. Director, 16.4% Owner Common Stock 873K Aug 14, 2024 By KVOI, L.P.
ACTUATE THERAPEUTICS, INC. Director, 16.4% Owner Common Stock 322K Aug 14, 2024 By Kairos SPV Fund, LLC
ACTUATE THERAPEUTICS, INC. Director, 16.4% Owner Common Stock 255K Aug 14, 2024 By Kairos-Actuate SPV, L.P.
ACTUATE THERAPEUTICS, INC. Director, 16.4% Owner Non-Qualified Stock Options 15K Aug 12, 2024 Direct
ACTUATE THERAPEUTICS, INC. Director, 16.4% Owner Series B-1 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 By KVP II, L.P.
ACTUATE THERAPEUTICS, INC. Director, 16.4% Owner Series B-2 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 By KVOI, L.P.
ACTUATE THERAPEUTICS, INC. Director, 16.4% Owner Series B-3 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 By Kairos SPV Fund, LLC
ACTUATE THERAPEUTICS, INC. Director, 16.4% Owner Series B-3 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 By KVOI, L.P.
ACTUATE THERAPEUTICS, INC. Director, 16.4% Owner Series B-3 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 By KVP II, L.P.
ACTUATE THERAPEUTICS, INC. Director, 16.4% Owner Series B-4 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 By Kairos-Actuate SPV, L.P.
ACTUATE THERAPEUTICS, INC. Director, 16.4% Owner Series B-4 Redeemable Convertible Preferred Stock 0 Aug 14, 2024 By Kairos SPV Fund, LLC
ACTUATE THERAPEUTICS, INC. Director, 16.4% Owner Series C Redeemable Convertible Preferred Stock 0 Aug 14, 2024 By Kairos-Actuate SPV, L.P.
ACTUATE THERAPEUTICS, INC. Director, 16.4% Owner Series C Redeemable Convertible Preferred Stock 0 Aug 14, 2024 By Kairos SPV Fund, LLC
ACTUATE THERAPEUTICS, INC. Director, 16.4% Owner Warrant (Right to Buy) 0 Aug 14, 2024 By KVP II, L.P.

Insider Reports Filed by Todd Thomson

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACTU ACTUATE THERAPEUTICS, INC. Aug 12, 2024 22 $5.28 4 Aug 16, 2024 Director, 16.4% Owner
ACTU ACTUATE THERAPEUTICS, INC. Aug 12, 2024 0 $0 3 Aug 12, 2024 Director, 16.4% Owner
DFLIW Chardan NexTech Acquisition 2 Corp. Aug 10, 2021 0 $0 3 Aug 10, 2021 Director